The Amyloidosis Channel is supported with funding from Prothena (Silver).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwMyeloma 2022 | The importance of early diagnosis in AL amyloidosis
In this video, Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN, discusses the importance of early diagnosis and detection in AL amyloidosis. Dr Dispenzieri first highlights the importance of educating and raising awareness of the disease, and considering patients with smoldering myeloma and monoclonal gammopathy of undetermined significance (MGUS) as possible AL patients. Dr Dispenzieri also discusses the importance of making the correct diagnosis and typing for different types of amyloidosis to ensure that the appropriate treatment is provided. This interview took place at The International Workshop on Myeloma 2022, held in Scottsdale, AZ.
